- Domagrozumab Ph II study did not meet primary endpoint
- Pfizer is also developing a gene therapy, PF-06939926, for DMD
- PF-06939926 has orphan status in the US and Europe... read more
... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,